ACET
Adicet Bio Inc
6.50$
-0.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | 100.0% | – | – | – | 100.0% | – | – | – | – | – | – | – | |
| 75.9% | 75.5% | 77.7% | 66.2% | 0.0% | – | 85.1% | 59.2% | 84.5% | – | – | 4,225.3% | – | 11,366.8% | – | – | – | – | – | – | – | -10.1% | 4.0% | – | – | – | – | – | – | 13.1% | – | – | – | – | – | – | – | – | – | – | – | |
| 24.1% | 24.5% | 22.3% | 33.8% | 0.0% | – | 14.9% | 40.8% | 15.5% | – | 100.0% | 100.0% | – | -11,266.8% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | – | – | – | – | – | – | 86.9% | – | – | – | 50.0% | – | – | – | – | – | – | – | |
| 0.8% | 1.1% | 1.4% | 2.6% | 1.8% | – | 4.4% | 12.4% | 4.1% | – | 180.9% | 176.4% | – | 331.3% | 351.7% | 116.2% | 295.3% | 179.0% | – | 220.5% | 347.8% | 268.1% | 54.0% | – | – | – | – | – | – | 192.0% | – | – | – | 357.7% | – | – | – | – | – | – | – | |
| 16.4% | 22.4% | 13.9% | 1.1% | 16.8% | – | 1.1% | 2.4% | 1.4% | – | 76.9% | 63.3% | – | 133.2% | 126.2% | 99.4% | 255.6% | 93.8% | – | 104.4% | 152.0% | 116.2% | 27.2% | – | – | – | – | – | – | 52.8% | – | – | – | 114.8% | – | – | – | – | – | – | – | |
| 17.2% | 23.4% | 15.3% | 3.6% | 2.1% | – | 5.5% | 14.7% | 5.5% | – | 254.5% | 184.4% | – | 464.5% | 477.9% | 215.6% | 551.0% | 272.8% | – | 324.9% | 499.8% | 384.2% | 81.2% | – | – | – | – | – | – | 244.8% | – | – | – | 472.5% | – | – | – | – | – | – | – | |
| 6.8% | 1.1% | 6.9% | 30.2% | -2.1% | – | -5.5% | -14.7% | -5.5% | – | -157.8% | -139.7% | – | -364.5% | -377.9% | -115.6% | -451.0% | -172.8% | – | -224.9% | -399.8% | -284.2% | 18.8% | – | – | – | – | – | – | -244.8% | – | – | – | -472.5% | – | – | – | – | – | – | – | |
| 1.7% | 2.1% | 2.8% | 2.8% | 2.9% | – | 2.7% | 0.3% | 3.7% | – | – | – | – | 106.4% | 16.1% | 0.5% | 1.7% | 0.9% | – | 1.1% | 1.5% | 0.5% | 0.1% | – | – | – | – | – | – | 0.4% | – | – | – | 0.0% | – | – | – | – | – | – | – | |
| 5.3% | -0.7% | 4.5% | 34.4% | -1.8% | – | -5.3% | -14.2% | -5.1% | – | -149.2% | -80.2% | – | -333.2% | -358.3% | -113.3% | -488.0% | -168.2% | – | -223.9% | -408.3% | -289.0% | 18.5% | – | – | – | – | – | – | -228.7% | – | – | – | -441.5% | – | – | – | – | – | – | – | |
| 1.9% | -0.3% | 1.5% | 12.3% | 0.9% | – | 2.7% | 0.0% | 0.0% | – | 0.3% | 0.0% | – | 0.9% | -134.0% | 0.0% | 0.1% | -2.6% | – | 1.6% | 0.3% | 0.2% | 0.4% | – | – | – | – | – | – | 11.7% | – | – | – | – | – | – | – | – | – | – | – | |
| 3.4% | -0.4% | 2.9% | 22.1% | -1.8% | – | -5.3% | -14.2% | -5.1% | – | -149.2% | -80.2% | – | -334.1% | -224.3% | -113.3% | -488.1% | -165.6% | – | -225.5% | -408.7% | -289.2% | 18.5% | – | – | – | – | – | – | -228.7% | – | – | – | -441.5% | – | – | – | – | – | – | – | |
| 10.6% | 5.5% | 12.6% | 28.3% | -1.8% | – | -5.3% | -14.7% | -5.5% | – | -146.2% | -129.8% | – | -350.5% | -342.6% | -108.6% | -476.9% | -161.4% | – | -213.3% | -395.6% | -281.9% | 20.0% | – | – | – | – | – | – | -215.6% | – | – | – | -416.6% | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.